MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ctarc.2026.101284

Медицинская библиотека · Cancer treatment and research communications · 2026

Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastases.

de Souza Carvalho Giselle, Delmonico Lucas, Alves Gilda, Ornellas Maria Helena, Rodrigues Fabiana Resende, Fernandes Priscila Valverde, Small Isabele Ávila, da Silva Jessé Lopes, Araujo Luiz Henrique Lima

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Breast cancer (BC) is a heterogeneous disease, and its molecular and immunohistochemical (IHC) profiles may change over time, particularly under therapeutic pressure. IHC discordance between primary tumors and BC brain metastases (BCBM) has been reported, yet its biological and clinical significance remains incompletely defined. Genomic profiling using next-generation sequencing (NGS) may provide additional insight into tumor evolution and clonal selection, although data from paired BC and BCBM are limited.

METHODS

This translational case series included six patients randomly selected from an institutional cohort of BC patients who underwent neurosurgical resection of BCBM. IHC reassessment (ER, PR, and HER2) and NGS profiling using targeted panels were performed.

RESULTS

Three of the six cases presented with IHC discordance, mainly loss of HR expression and gain of HER2 in BCBM. Genomic profiling identified 23 mutations in primary tumors compared with four in BCBM. BRCA1/2 variants predominated in primary tumors (21/23, 91%), most predicted to result in loss-of-function alterations. One mutation (PIK3CA/N345K) was shared between primary and metastatic tissues within the same patient. Overall survival ranged from 28 to 146 months.

CONCLUSION

This paired analysis demonstrates immunophenotypic and genomic divergence between BC and BCBM, supporting the concept of dynamic tumor evolution. Receptor conversion and emergence or loss of actionable genomic alterations highlight the potential value of repeat molecular assessment in advanced stages. Although limited by a small sample size, retrospective design, and absence of matched germline testing, these findings reinforce the importance of integrating biomarker reevaluation into the management of selected patients.

Для цитирования: de Souza Carvalho Giselle, Delmonico Lucas, Alves Gilda, Ornellas Maria Helena, Rodrigues Fabiana Resende, Fernandes Priscila Valverde, Small Isabele Ávila, da Silva Jessé Lopes, Araujo Luiz Henrique Lima. Translational case series comparing next-generation sequencing profiles of primary breast cancer and brain metastases.. Cancer treatment and research communications. 2026. DOI: 10.1016/j.ctarc.2026.101284.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.